Skip to main content
. 2020 May 19;182(1):107–115. doi: 10.1007/s10549-020-05683-6

Table 2.

Changes in total decisional conflict scores and sub-scores with regard to the decision to undergo adjuvant chemotherapy for the total cohort of estrogen receptor positive breast cancer patients before and after being informed on the results of the 70-gene signature test (n = 106)

Decisional conflict scores
Pre-test score Post-test score P-value*
Total 35 23  < 0.001
Sub-scores
Informed score 28 19  < 0.001
Clarity score 35 22  < 0.001
Support score 25 22 0.26
Uncertainty score 47 28  < 0.001
Effective decision score 37 25  < 0.001

*P-values represent Wilcoxon signed-rank test